Injectable Drug Delivery Market - Forecast(2019 - 2024)

Report Code: HCR 0023 Report Format: PDF + Excel Database

Drug Delivery Market Overview:

Annually, medical error causes 250,000 deaths in the US, which is the third leading cause of death in the North American region.[1] Medical treatment based on medication targeted to treat one's bodily disorder can produce severe repercussions to other unintended body parts. Albeit the curative efficacy for treating cancer, chemotherapy, for instance, causes several side effects such as headaches, blood disorders, heart disorders, and various other post health issues. Modern technology and biological advancement is set to overcome these challenges to effective medication with drug delivery systems owing to its effective therapeutic effects. Specialized in actively treating any particular malfunctioning area in the body without adversely affecting any other bodily functions, these targeted therapies have become an alternative to many conventional medical treatments. 

The global drug delivery market value attained $17.50 billion in the year 2018. Drug delivery procedure includes oral, inhalation, injection, and transdermal absorption of the drug to the targeted part, resultantly uplifting the treatment methods for various diseases. The prominent benefits of drug delivery in the associated healthcare facilities around the world has propelled the global drug delivery market. As per the evaluation, the huge demand for the drug delivery devices generated by the increasing population will grow at a compound annual growth rate (CAGR) of 7.20% through to 2019-2025.

Drug Delivery Market Outlook:

The drug delivery provided in the medical and healthcare sector include various types of advanced technological devices systems such as intrauterine implants, targeted drug delivery, polymeric drug delivery, and many others. The increasing number of healthcare facilities and the widespread chronic diseases are some of the major factors influencing the drug delivery market growth in North America, which held a huge global market share of 36% in 2018, and the demand will have an unprecedented growth in the foreseeable future. The possible ability of drug delivery to substitute therapeutic treatment, which pose risks of affecting on non-targeted body parts induces wide acceptance of this system by the hospitals and patients. The key application of drug delivery in conventional injection devices will have an effective CAGR of 6.70% through to 2025.

Drug Delivery Market Growth Drivers:

·         Increasing incidences of chronic disease such as cancer across the world is majorly driving the global drug delivery market owing to the effective and targeted drug release along with minimal side-effects on the body.

·      Rising population of the old-age majority demands greater supply of generic drugs and doses. Growing age accompanies several diseases resulting in an upsurge of the drug delivery market.

·        Incrementing global biologics and biosimilar market is inducing a positive influence on the global drug delivery market owing to a lucrative market revenue.

·     New innovations, technological advancement, and promotion of new products propelled by the key manufacturers in the global market, wide scope of development and profitable outcome is accomplished by the drug delivery market.

Drug Delivery Market Challenges:

The nanoparticles of drug delivery systems are made up of certain substances which reacts with the cellular membranes resulting in morphological changes. Moreover, certain drug delivery devices are partially or completely insoluble in nature becoming a barrier in the blood streams. This may lead to several other health issues creating severe problems. Medical researches executed and other biotechnological advancements conducted by the pharmaceutical industries are constantly limiting these drawbacks through their innovative and cost-efficient drug delivery systems.

Drug Delivery Market Key Players:

The pioneers in the global drug delivery market include companies like Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer AG, Schott AG, Eli Lilly and Company, and Terumo Corporation, and others.

Dickinson and Company is an American based leading medical technology company delivers various ergonomic drug delivery systems including prefillabe syringes, self-injection systems, safety and shielding devices to more than 500 companies, which reduces pain and enhances the delivery span to ultimately provide the patients a healthy medication.

Drug Delivery Market Trends:

·         Advanced Prodrug Implants

Prodrug therapy offers two-step solution for cancerous cells and is used as an alternative treatment to chemotherapy. Antibodies are delivered to the particular cancer sites in the body, thereby targeting the enzymes of the cancer cells and releasing prodrug to kill the cancer cells without affecting any normal cells.

·         Chip-Based Drug Delivery

Microchip drug delivery is an advanced medical technology which when injected into a body system or consumed orally remains inside the body and releases drug doses at regular and fixed intervals over a great time span. Without any interventions of the bearer, this modern drug delivery system is gaining large scale demand from different end-users owing to its potential benefits in treating chronic diseases.

·         Cellular Delivery Technology

The potentiality of cells as carrier of drugs is exploited by modern medical science and technology. Cellular drug delivery emerges as an alternative to nano and micro drug delivery particles with efficiency in the treatment of HIV, cancer, cardiovascular diseases, and other body abnormalities.

Drug Delivery Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Drug Delivery Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of drug delivery in Drug Delivery Market, and their specific applications in different areas.

Drug Delivery Market Report: Industry Coverage:

The drug delivery market is generally divided into segments by technology, application, and end users. On the basis of technology, the market is bifurcated into syringes, inhalers, intrauterine devices, powered injectors, and others. Based on application types the segmentation includes oncology, cardiology, gynecology, asthma, diabetes, and others. By end users this market is categorized into patients, hospital, clinics, and many others.

The Drug Delivery Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

•           North America: The U.S., Canada, Mexico

•           South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

•           Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

•           APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

•           Middle East and Africa: Israel, South Africa, Saudi Arabia


Reference:

[1] https://sciencebasedmedicine.org/are-medical-errors-really-the-third-most-common-cause-of-death-in-the-u-s-2019-edition/

1. Injectable Drug Delivery Market - Overview
1.1. Definitions and Scope
2. Injectable Drug Delivery Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Injectable Drug Delivery Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Injectable Drug Delivery Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Injectable Drug Delivery Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Injectable Drug Delivery Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Injectable Drug Delivery Market - Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Injectable Drug Delivery Market – Market By Delivery Devices (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Market Overview 
8.3.2. Conventional Injection Devices Market 
8.3.3. Self-Injection Devices Market 
8.3.4. Auto Drug Injecting Devices 
8.3.4.1. By Drug Loading
8.3.4.1.1. Prefilled Auto Injectors 
8.3.4.1.2. Fillable Auto Injectors
8.3.4.1.3. By User Intervention 
8.3.4.1.4. Automated Auto Injectors
8.3.4.1.5. Manual Auto Injectors 
8.3.4.1.6. By Design 
8.3.4.1.6.1. Standard Auto Injectors 
8.3.4.1.6.2. Customized Auto Injectors 
8.3.4.1.7. By Reusability 
8.3.4.1.7.1. Disposable Auto Injectors 
8.3.4.1.7.2. Reusable Auto Injectors 
8.3.5. Pen Injectors 
8.3.5.1. By Product 
8.3.5.1.1. Single Chamber Pen Injectors 
8.3.5.1.2. Dual Chamber Pen Injectors 
8.3.5.2. By Reusability 
8.3.5.2.1. Disposable Pen Injectors 
8.3.5.2.2. Reusable Pen Injectors 
8.3.5.3. By Design 
8.3.5.3.1. Standardized Pen Injectors 
8.3.5.3.2. Customized Pen Injectors
8.3.6. Needle Free Drug Injection Devices 
8.3.6.1. By Drug Loading
8.3.6.1.1. Prefilled Needle Free Injectors
8.3.6.1.2. Fillable Needle Free Injectors
8.3.6.2. By Technology
8.3.6.2.1. Jet-Based Needle-Free Injectors
8.3.6.2.2. Spring-Based Needle-Free Injectors
8.3.6.2.3. Laser-Based Needle Free Injectors
8.3.6.2.4. Vibration-Based Needle Free Injectors
8.3.6.3. By Reusability
8.3.6.3.1. Disposable Needle Free Injectors
8.3.6.3.2. Reusable Needle Free Injectors
8.3.7. Conventional Drug Injection Devices
8.3.7.1. By Reusability
8.3.7.1.1. Disposable Injection Devices 
8.3.7.1.2. Reusable Injection Devices 
8.3.7.2. By Material
8.3.7.2.1. Glass Based Injectors 
8.3.7.2.2. Plastic Based Injectors
8.3.7.3. By Drug Loading
8.3.7.3.1. Prefilled Injection Devices 
8.3.7.3.2. Fillable Injection Device
8.3.8. Wearable injectors
8.3.9. Safety syringes
8.3.10. Integrated safety syringes
8.3.11. Patch injectors
8.3.12. Subcutaneous infusion devices
9. Injectable Drug Delivery Market – By Drug Formulations (Market Size -$Million / $Billion)
9.1. Conventional Drug Delivery Formulations 
9.1.1. Injectable Drug Delivery Formulation Solutions 
9.1.2. Reconstituted Drug Delivery Formulation Solutions
9.2. Novel Drug Delivery Formulation Solutions
9.2.1. Liposomal Systems 
9.2.2. Microspheres 
9.2.3. Nanoparticles
9.2.4. Polymeric Micelles
9.2.5. Others
10. Injectable Drug Delivery Market – By Therapeutic Areas (Market Size -$Million / $Billion)
10.1. Auto-Immune Diseases 
10.1.1. Multiple Sclerosis 
10.1.2. Rheumatoid Arthritis 
10.1.3. Crohn's Diseases 
10.1.4. Psoriasis 
10.1.5. Others 
10.2. Hormonal Disorders 
10.2.1. Diabetes 
10.2.2. Anemia 
10.2.3. Reproductive Health Diseases 
10.2.4. Osteoporosis 
10.2.5. Growth Hormone Deficiency 
10.2.6. Antithrombotic Therapy 
10.3. Orphan or Rare Diseases 
10.4. Oncology 
10.5. Others 
10.5.1. Pain Management 
10.5.2. Hepatitis C 
10.5.3. Allergies 
10.5.4. Aesthetic Treatment
11. Injectable Drug Delivery Market – By application (Market Size -$Million / $Billion)
11.1. Diabetes
11.2. Cardiovascular diseases
11.3. Autoimmune diseases
11.4. Hormones replacement
11.5. Neurology addiction
11.6. Respiratory diseases
11.7. others
12. Injectable Drug Delivery – By End User(Market Size -$Million / $Billion)
12.1. Segment type Size and Market Share Analysis 
12.2. Application Revenue and Trends by type of Application
12.3. Application Segment Analysis by Type
12.3.1. Homecare
12.3.2. Professional care
12.3.2.1. Hospitals
12.3.2.2. clinics
13. Injectable Drug Delivery - By Geography (Market Size -$Million / $Billion)
13.1. Injectable Drug Delivery Market - North America Segment Research
13.2. North America Market Research (Million / $Billion)
13.2.1. Segment type Size and Market Size Analysis 
13.2.2. Revenue and Trends
13.2.3. Application Revenue and Trends by type of Application
13.2.4. Company Revenue and Product Analysis
13.2.5. North America Product type and Application Market Size
13.2.5.1. U.S.
13.2.5.2. Canada 
13.2.5.3. Mexico 
13.2.5.4. Rest of North America
13.3. Injectable Drug Delivery - South America Segment Research
13.4. South America Market Research (Market Size -$Million / $Billion)
13.4.1. Segment type Size and Market Size Analysis 
13.4.2. Revenue and Trends
13.4.3. Application Revenue and Trends by type of Application
13.4.4. Company Revenue and Product Analysis
13.4.5. South America Product type and Application Market Size
13.4.5.1. Brazil  
13.4.5.2. Venezuela
13.4.5.3. Argentina
13.4.5.4. Ecuador
13.4.5.5. Peru
13.4.5.6. Colombia 
13.4.5.7. Costa Rica
13.4.5.8. Rest of South America
13.5. Injectable Drug Delivery - Europe Segment Research
13.6. Europe Market Research (Market Size -$Million / $Billion)
13.6.1. Segment type Size and Market Size Analysis 
13.6.2. Revenue and Trends
13.6.3. Application Revenue and Trends by type of Application
13.6.4. Company Revenue and Product Analysis
13.6.5. Europe Segment Product type and Application Market Size
13.6.5.1. U.K  
13.6.5.2. Germany 
13.6.5.3. Italy 
13.6.5.4. France
13.6.5.5. Netherlands
13.6.5.6. Belgium
13.6.5.7. Spain
13.6.5.8. Denmark
13.6.5.9. Rest of Europe
13.7. Injectable Drug Delivery – APAC Segment Research
13.8. APAC Market Research (Market Size -$Million / $Billion)
13.8.1. Segment type Size and Market Size Analysis 
13.8.2. Revenue and Trends
13.8.3. Application Revenue and Trends by type of Application
13.8.4. Company Revenue and Product Analysis
13.8.5. APAC Segment – Product type and Application Market Size
13.8.5.1. China 
13.8.5.2. Australia
13.8.5.3. Japan 
13.8.5.4. South Korea
13.8.5.5. India
13.8.5.6. Taiwan
13.8.5.7. Malaysia
14. Injectable Drug Delivery Market - Entropy
14.1. New product launches
14.2. M&A's, collaborations, JVs and partnerships
15. Injectable Drug Delivery Market – Industry / Segment Competition landscape Premium
15.1. Market Share Analysis
15.1.1. Market Share by Country- Top companies
15.1.2. Market Share by Region- Top 10 companies
15.1.3. Market Share by type of Application – Top 10 companies
15.1.4. Market Share by type of Product / Product category- Top 10 companies
15.1.5. Market Share at global level- Top 10 companies
15.1.6. Best Practices for companies
16. Injectable Drug Delivery Market – Key Company List by Country Premium
17. Injectable Drug Delivery Market Company Analysis
17.1. Market Share, Company Revenue, Products, M&A, Developments
17.2. Terumo Corp
17.3. Schott AG
17.4. SHL group
17.5. Owen Mumford ltd
17.6. Sanofi
17.7. Novo nordix
17.8. Company 8
17.9. Company 9 and more
"*Financials would be provided on a best efforts basis for private companies"
18. Injectable Drug Delivery Market - Appendix
18.1. Abbreviations
18.2. Sources
19. Injectable Drug Delivery Market - Methodology
19.1. Research Methodology
19.1.1. Company Expert Interviews
19.1.2. Industry Databases
19.1.3. Associations
19.1.4. Company News
19.1.5. Company Annual Reports
19.1.6. Application Trends
19.1.7. New Products and Product database
19.1.8. Company Transcripts
19.1.9. R&D Trends
19.1.10. Key Opinion Leaders Interviews
19.1.11. Supply and Demand Trends
List of Tables :

Table 1. Key Company Products, Conventional Injection Devices Market
Table 2. Key Company Products, Self-Injection Devices Market
Table 3. Key Company Products, Needle Free Injection Devices Market
Table 4. Key Company Products, Auto Injector Devices Market
Table 5. Key Company Products, Pen Injection Devices Market
Table 6. Global Diabetic Cases (Millions) and Prevelance Rates (%), 2011 and 2030
Table 7. Global Injectable Drug Delivery Devices Market, By Product, 2010 - 2018 ($Billion)
Table 8. Global Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 9. Global Self-Injection Devices Market, By Product, 2010 - 2018 ($Billion)
Table 10. Global Self-Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 11. Global Others Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 12. Global Auto Injectors Products Market, By Geography, 2010 - 2018 ($Million)
Table 13. Global Auto Injectors Market, By Drug Loading, 2010 - 2018 ($Million)
Table 14. Global Prefilled Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 15. Global Fillable Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 16. Global Auto Injectors Market, By User Intervention, 2010 - 2018 ($Million)
Table 17. Global Automated Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 18. Global Manual Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 19. Global Auto Injectors Market, By Design, 2010 - 2018 ($Million)
Table 20. Global Standardized Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 21. Global Customized Auto Injectors Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 22. Global Auto Injectors Market, By Reusability, 2010 - 2018 ($Million)
Table 23. Global Disposable Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 24. Global Reusable Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 25. Global Pen Injector Market, By Geography, 2010 - 2018 ($Million)
Table 26. Global Pen Injectors Market, By Product, 2010 - 2018 ($Million)
Table 27. Global Single Chamber Pen Injector Market, By Geography, 2010 - 2018 ($Million)
Table 28. Global Dual Chamber Pen Injector Market, By Geography, 2010 - 2018 ($Million)
Table 29. Global Pen Injectors Market,By Reusability, 2010 - 2018 ($Million)
Table 30. Global Disposable Pen Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 31. Global Reusable Pen Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 32. Global Pen Injectors Market, By Design, 2010 - 2018 ($Million)
Table 33. Global Standard Pen Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 34. Global Customized Pen Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 35. Global Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 36. Global Needle Free Injectors Market, By Drug Loading, 2010 - 2018 ($Million)
Table 37. Global Prefilled Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 38. Global Fillable Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 39. Global Needle Free Injectors Market, By Technology, 2010 - 2018 ($Million)
Table 40. Global Jet-Based Needle Free Injector Market, By Geography, 2010 - 2018 ($Million)
Table 41. Global Spring-Based Needle Free Injector Market, By Geography, 2010 - 2018 ($Million)
Table 42. Global Laser-Powered Needle Free Injector Market, By Geography, 2010 - 2018 ($Million)
Table 43. Global Vibration-Based Needle Free Injector Market, By Geography, 2010 - 2018 ($Million)
Table 44. Global Needle Free Injectors Market, By Reusability, 2010 - 2018 ($Million)
Table 45. Global Disposable Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 46. Global Reusable Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 47. Global Conventional Injection Devices Market, By Reusability, 2010 - 2018 ($Billion)
Table 48. Global Disposable Conventional Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 49. Global Reusable Conventional Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 50. Global Conventional Injection Devices Market, By Material, 2010 - 2018 ($Billion)
Table 51. Global Glass Based Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 52. Global Plastics Based Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 53. Global Conventional Injection Devices Market, By Drug Loading, 2010 - 2018 ($Billion)
Table 54. Global Prefilled Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 55. Global Fillable Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 56. Global Injectable Drug Delivery Market, By Formulation Delivery Types, 2010 - 2018 ($Billion)
Table 57. Global Injectable Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Billion)
Table 58. Global Conventional Drug Delivery Formulations Market, By Dosage Form, 2010 – 2018 ($Billion)
Table 59. Global Conventional Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Billion)
Table 60. Global Injectable Conventional Drug Delivery Formulation Solutions, By Geography, 2010 - 2018 ($Billion)
Table 61. Global Reconstituted Conventional Drug Delivery Formulation Solutions, By Geography, 2010 - 2018 ($Billion)
Table 62. Global Novel Drug Delivery Formulations Market, By Delivery Systems, 2010 - 2018 ($Billion)
Table 63. Global Novel Drug Delivery Formulation Solutions Market, By Geography, 2010 - 2018 ($Billion)
Table 64. Global Liposomal Systems Based Drug Delivery Formulations, By Geography, 2010 - 2018 ($Million)
Table 65. Global Microspheres Based Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Million)
Table 66. Global Nanoparticles Based Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Million)
Table 67. Global Polymeric Micelles Based Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Million)
Table 68. Other Novel Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Billion)
Table 69. Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications, 2010 - 2018 ($Million)
Table 70. Global Auto-Immune Therapeutic Market, By Indication, 2010 - 2018 ($Million)
Table 71. Global Auto-Immune Therapeutic Market, By Geography, 2010 - 2018 ($Million)
Table 72. Global Multiple Sclerosis Market, By Geography, 2010 - 2018 ($Million)
Table 73. Global Rheumatoid Arthritis Market, By Geography, 2010 - 2018 ($Million)
Table 74. Global Crohn's Diseases Market, By Geography, 2010 - 2018 ($Million)
Table 75. Global Psoriasis Market, By Geography, 2010 - 2018 ($Million)
Table 76. Other Auto-Immune Diseases Market, By Geography, 2010 - 2018 ($Million)
Table 77. Global Hormonal Disorder Therapeutics Market, By Indication, 2010 - 2018 ($Million)
Table 78. Global Hormonal Disorders Therapeutics Market, By Geography, 2010 – 2018 ($Billion)
Table 79. Global Diabetes Therapeutics Market, By Geography, 2010 - 2018 ($Billion)
Table 80. Global Anemia Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 81. Global Reproductive Health Diseases Therapeutics Market, By Geography, 2010 - 2018($Million)
Table 82. Globalosteoporosis Therapeutics Market, By Geography, 2010 - 2018($Million)
Table 83. Global Growth Hormone Deficiency Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 84. Global Antithrombotic Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 85. Global Orphan/Rare Diseases Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 86. Global Oncology Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 87. Global Other Therapeutics Market, 2010 - 2018 ($Million)
Table 88. Global Other Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 89. Global Pain Management Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 90. Global Hepatitis C Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 91. Global Allergies Therapeutics Market, By Geography 2010 - 2018 ($Million)
Table 92. Global Aesthetic Treatment Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 93. North America Injectable Drug Delivery Technologies Market,2010 - 2018 ($Billion)
Table 94. North America Injectable Drug Delivery Devices Market, By Segment, 2010 - 2018 ($Billion)
Table 95. North America Injectable Drug Delivery Formulation Solutions Market, 2010 - 2018 ($Billion)
Table 96. North America Injectable Drug Delivery Market, By Therapeutic Areas, 2010 - 2018 ($Billion)
Table 97. Europe Injectable Drug Delivery Technologies Market, 2010 - 2018 ($Billion)
Table 98. Europe Injectable Drug Delivery Devices Market, 2010 - 2018 ($Million)
Table 99. Europe Injectable Drug Delivery Formulation Solutions Market, By Segment, 2010 - 2018 ($Billion)
Table 100. Europe Injectable Drug Delivery Market, By Therapeutic Areas, 2010 - 2018 ($Billion)
Table 101. Asia Pacific Injectable Drug Delivery Technologies Market, By Segment,2010 - 2018 ($Billion)
Table 102. Asia Pacific Injectable Drug Delivery Devices Market, By Segment, 2010 - 2018 ($Million)
Table 103. Asia Pacific Injectable Drug Delivery Formulation Solutions Market, By Segment, 2010 - 2018 ($Billion)
Table 104. Asia Pacific Injectable Drug Delivery Market, By Therapeutic Areas, 2010 - 2018 ($Million)
Table 105. Rest of World Injectable Drug Delivery Technologies Market, By Segment, 2010 - 2018 ($Million)
Table 106. Rest of World Injectable Drug Delivery Devices Market, By Segment, 2010 - 2018 ($Million)
Table 107. Rest of World Injectable Drug Delivery Formulation Solutions Market, By Segment, 2010 - 2018 ($Million)
Table 108. Rest of World Injectable Drug Delivery Market, By Therapeutic Areas, 2010 - 2018 ($Million)
Table 109. Alkermes: Total Revenue and R&D Expenses,2011– 2013 ($Million)
Table 110. Alkermes: Total Revenue, By Geography, 2011 – 2013 ($Million)
Table 111. Antares Pharma: Total Revenue and R&D Expenses,2010– 2012 ($Million)
Table 112. Antares Pharma: Total Revenue, By Geography,2010 – 2012 ($Million)
Table 113. Antares Pharma: Total Revenue, By Product,2010 – 2012 ($Million)
Table 114. Baxter International: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 115. Baxter International: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 116. Baxter International: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 117. Baxter International: Medical Products Total Revenue, 2010 – 2012($Million)
Table 118. Becton Dickinson: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 119. Becton Dickinson: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 120. Becton Dickinson: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 121. Becton Dickinson: Medical Divsion Total Revenue,  2010 – 2012($Million)
Table 122. Consort Medical: Total Revenue and R&D Expenses, 2011– 2013 ($Million)
Table 123. Consort Medical: Total Revenue, By Geography, 2011 – 2013 ($Million)
Table 124. Eli Lilly & Co: Total Revenue and R&D Expenses,2010– 2012 ($Billion)
Table 125. Eli Lilly & Co: Total Revenue, By Geography,2010 – 2012 ($Billion)
Table 126. Eli Lilly & Co: Total Revenue, By Segment, 2010 – 2012 ($Billion)
Table 127. Gerresheimer Ag: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 128. Gerresheimer Ag: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 129. Gerresheimer Ag: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 130. Novo Nordisk: Total Revenue and R&D Expenses, 2010– 2012 ($Billion)
Table 131. Novo Nordisk: Total Revenue, By Geography, 2010 – 2012 ($Billion)
Table 132. Novo Nordisk: Total Revenue, By Segment, 2010 – 2012 ($Billion)
Table 133. Sanofi: Total Revenue and R&D Expenses, 2010– 2012 ($Billion)
Table 134. Sanofi: Total Revenue, By Geography, 2010 – 2012 ($Billion)
Table 135. Sanofi: Total Revenue, By Segment, 2010 – 2012 ($Billion)
Table 136. Schott Ag: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 137. Schott Ag: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 138. Terumo Corporation: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 139. Terumo Corporation: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 140. Terumo Corporation: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 141. Unilife Corporation: Total Revenue and R&D Expenses, 2011– 2013 ($Million)
Table 142. Unilife Corporation: Total Revenue, By Segment, 2011 – 2013 ($Million)
Table 143. West Pharma: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 144. West Pharma: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 145. West Pharma: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 146. Ypsomed: Total Revenue and R&D Expenses, 2011– 2012 ($Million)
Table 147. Ypsomed: Total Revenue, By Geography, 2011-2012 ($Million)
Table 148. Ypsomed: Total Revenue, By Segment, 2011 – 2012 ($Million)
Table 149. Zogenix, Inc.: Total Revenue and R&D Expenses, 2010– 2012 ($Million)

 
List of Figures:

Figure 1. Drug Injection Devices Segmentation
Figure 2. Drug Injection Formulations Segmentation
Figure 3. Drug Injection Formulations Segmentation
Figure 4. Global Conventional Injection Devices Market Share Analysis (%), 2012
Figure 5. Global Self-Injection Devices Market Share Analysis (%), 2012
Figure 6. Global Auto Injector Devices Market Share Analysis (%), 2012
Figure 7. Global Pen Injector Devices Market Share Analysis (%), 2012
Figure 8. Global Needle Free Injector Devices Market Share Analysis (%), 2012
Figure 9. Global Diabetes Market, By Treatment Methods (%), 2012 and 2018
Figure 10. Injectable Drug Delivery Devices, Value Chain Analysis
Figure 11. Drug Delivery Injection Devices – Product Segmentation
Figure 12. Global Injectable Drug Delivery Market, By Geography, 2013 (%)
Figure 13. Global IDD Market M&A's, Collaborations, Jv's & Partnerships, By Company (2013)